NIH clinical trial testing hyperimmune intravenous immunoglobulin plus remdesivir to treat COVID-19 began
On Oct. 8, 2020, a clinical trial to test the safety, tolerability and efficacy of a combination treatment…
-
-
Gilead Sciences signed joint procurement agreement with European Commission for Veklury (remdesivir)
On Oct. 8, 2020, Gilead Sciences and the European Commission signed a joint procurement agreement (JPA) that enabled…
-
NIH launched the Serological Sciences Network for COVID-19, announced grant and contract awardees
On Oct. 8, 2020, the National Cancer Institute (NCI) launched the Serological Sciences Network for COVID-19 (SeroNet), an…
-
One stillbirth occurs every 16 seconds, according to first ever joint UN estimates
On Oct. 8, 2020, UNICEF, World Health Organization (WHO), the World Bank Group and the Population Division of…
-
Biotechnology | COVID-19 | Disease | Therapeutics | Vaccine
Relation between COVID-19 and Guillain-Barre syndrome in adults: a systematic review published
On Oct. 8, 2020, the relation between COVID-19 and Guillain-Barre syndrome (GBS) in adults: a systematic review was…
-
Johnson & Johnson announced EC approval of agreement to supply 200 million doses of COVID-19 vaccine candidate
On Oct. 8, 2020, Johnson & Johnson announced the European Commission, acting on behalf of the European Union…
-
Biotechnology | Infectious Disease | Influenza | Measles | Plague | Polio | Vaccine
DARPA awarded Moderna $56 Million to enable small-scale, rapid mobile manufacturing of vaccines and therapeutics
On Oct. 8, 2020, Moderna announced an agreement for a commitment of up to $56 million from the…
-
Kindred Biosciences announced expansion of Manufacturing agreement with Vaxart for COVID-19 and other vaccine candidates
On Oct. 7, 2020, Kindred Biosciences announced it had expanded an agreement with Vaxart for the manufacture of…
-
Lilly updated progress of SARS-CoV-2 neutralizing antibody programs
On Oct. 7, 2020, Eli Lilly announced additional details on its SARS-CoV-2 neutralizing antibody programs – including interim…
-
Mateon announced first patient enrolled in ARTI-19 multicenter interventional study of Artshield against COVID-19
On Oct. 7, 2020, Mateon Therapeutics announced the first patient enrolled this week in its Phase IV study…
-
Biotechnology | Clinical Research | COVID-19 | Diagnostics | FDA | Infectious Disease | Therapeutics
Abbott’s released ID NOW COVID-19 interim clinical study results to provide facts on clinical performance
On Oct. 7, 2020, in a continuing effort to provide the facts about ID NOW to support public…
-
Biotechnology | Chemistry | CRISPR | Genomics | Oncology | Therapeutics
Nobel Prize in Chemistry for 2020 awarded to Emmanuelle Charpentier and Jennifer A Doudna “for the development of a method for genome editing”
On Oct. 7, 2020, the Nobel Prize in Chemistry 2020 was awarded to Drs. Emmanuelle Charpentier and Jennifer…
-
Chemicals similar to those found in cannabis can inhibit bacterial virulence
On Oct. 7, 2020, UT Southwestern scientists showed that endocannabinoids, signaling molecules produced in the body that share…
-
Sonic Healthcare enhanced test offerings with launch of multiplex assay for COVID-19 and flu
On Oct. 7, 2020, Sonic Healthcare USA announced that it had launched a multiplex RT-PCR assay that combined…
-
RedHill Biopharma’s Opaganib COVID-19 study passed second independent committee review
On Oct. 7, 2020, RedHill Biopharma announced that the U.S. Phase 2 study with opaganib (Yeliva, ABC294640)1 in…
-
Rentschler Biopharma contributed to manufacturing of COVID-19 mRNA vaccine
On Oct. 7, 2020, Rentschler Biopharma announced an agreement to serve as CDMO partner for BioNTech. As an…
-
Sorrento announced discovery of salicyn-30 small molecule that strongly inhibits SARS-CoV-2 infection
On Oct. 7, 2020, Sorrento Therapeutics announced that it had discovered a small molecule termed Salicyn-30 that demonstrated…
-
NIH RADx initiative advanced six new COVID-19 testing technologies
On Oct. 6, 2020, the National Institutes of Health (NIH), working in collaboration with the Biomedical Advanced Research…
-
SARS-CoV-2 may use key carbohydrate to infect cells
On Oct. 6, 2020, National Institutes of Health (NIH) researchers announced they had found that a carbohydrate called…
-
NIH supported 85 new grants featuring high-risk, high-reward research
On Oct. 6, 2020, the National Institutes of Health (NIH) announced it had awarded 85 grants through its…
-
HHS funded development of needle-free vaccine administration technology
On Oct. 6, 2020, the U.S. Department of Health and Human Services (HHS) announced funding of a patch…
-
BioNTech and Pfizer initiated a rolling submission to EMA for SARS-CoV-2 vaccine candidate BNT162b2
On Oct. 6, 2020, Pfizer and BioNTech announced the initiation of a rolling submission to the European Medicines…
-
AIM ImmunoTech announced approval to enroll COVID-19 ‘long haulers’ in AMP-511 ME/CFS clinical trial of Ampligen
On Oct. 6, 2020, AIM ImmunoTech announced that it had received Institutional Review Board approval for the expansion…
-
National Science Foundation announced investment of $40 million in future of US manufacturing
On Oct. 6, 2020, the National Science Foundation (NSF) announced investments in 24 new projects to drive future…
-
Broad and Brigham and Women’s Hospital launched COVID-19 surveillance study
On Oct. 6, 2020, clinicians and researchers from Brigham and Women’s Hospital, the Broad Institute of MIT and…
-
Data from Corvus phase 1 study of CPI-006 continued to support its potential as treatment for COVID-19
On Oct. 5, 2020, Corvus Pharmaceuticals announced updated data from its ongoing Phase 1 study investigating the potential…
-
Bristol Myers Squibb to acquire MyoKardia for $13.1 billion in cash
On Oct. 5, 2020, Bristol-Myers and MyoKardia announced a definitive merger agreement under which Bristol Myers Squibb will…
-
NIH awarded $13.8 million for studies on the prevention and treatment of Alzheimer’s disease
On Oct. 5, 2020, Joe Verghese, M.B.B.S., M.S., an international leader in aging and cognition research at Albert…
-
The Nobel Prize in Medicine for 2020 was awarded to Harvey J Alter, Michael Houghton and Charles M Rice
On Oct. 5, 2020, the Nobel Prize in Medicine 2020 was awarded to Harvey J. Alter, Michael Houghton…
-
The CDC updated ‘how COVID is spread’
On Oct. 5, 2020, the U.S. Centers for Disease Control and Prevention (CDC) announced the existence of published…
